Location: United States
Total raised: $52M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.05.2026 | Series D | $52M | - |
Mentions in press and media 6
| Date | Title | Description |
| 01.06.2026 | ClearNote Health Secures $52M to Expand Early Cancer Detection | ClearNote Health secured $52 million in Series D funding. This capital fuels accelerated growth in early cancer detection. The round elevates total funding to $185 million. New President and COO Kevin Keegan joins the leadership. ClearNote ... |
| 27.05.2026 | Protuoso Biosciences Raises $9.5M in Seed Funding | Protuoso Biosciences, a San Carlos, CA-based biotechnology company developing multifunctional biologics designed to address complex disease biology, raised $9.5M in Seed funding. The round was led by Taya Venture and Darwin Ventures, with p... |
| 27.05.2026 | Sychedelic Raises $3.5M in Seed Funding | Sychedelic, a NYC-based consumer neurotechnology company building brain wearables, raised $3.5M in Seed funding. The round was led by Cultadvisors LLP, TurboStart, and IdeaBaaz (Kuberan Ventures). The company intends to use the funds to sup... |
| 27.05.2026 | ClearNote Health Raises $52M in Series D Funding | ClearNote Health, a San Diego, CA-based company dedicated to improving early detection for cancer, raised $52M in Series D funding. The round was led by Mattias Westman and an other undisclosed investor, with participation from former CEO a... |
| 27.05.2026 | ClearNote Health: $52 Million Series D Raised To Accelerate Early Cancer Detection Growth | ClearNote Health announced it has secured $52 million in Series D financing and appointed clinical oncology diagnostics veteran Kevin Keegan as president and chief operating officer. The company said the funding and leadership expansion wil... |
| - | ClearNote Health | “The key to managing cancer is early detection. ClearNote Health makes this possible by finding signals of cancer in the blood early” |